Aquestive Therapeutics, Inc. AQST EPS (Diluted)
EPS (Diluted) at other companies
Other financials
Where this comes from
Reported directly by Aquestive Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:EarningsPerShareDiluted.
The official record: Aquestive Therapeutics, Inc.’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Aquestive Therapeutics, Inc.'s eps (diluted).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Aquestive Therapeutics, Inc.'s EPS (diluted)?
- Aquestive Therapeutics, Inc. (AQST) reported EPS (diluted) of -$0.07 in Q1 2026.
- How has Aquestive Therapeutics, Inc.'s EPS (diluted) changed year-over-year?
- Aquestive Therapeutics, Inc.'s EPS (diluted) increased by 70.8% year-over-year, from -$0.24 to -$0.07.
- What is the long-term trend for Aquestive Therapeutics, Inc.'s EPS (diluted)?
- Over 4 years (2021 to 2025), Aquestive Therapeutics, Inc.'s EPS (diluted) has grown at a -19.1% compound annual growth rate (CAGR), from -$1.84 to -$0.79.
- What does EPS (diluted) mean?
- Net income divided by the weighted-average number of shares outstanding plus all potentially dilutive securities (stock options, convertibles, warrants). The most conservative EPS measure.